Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Johnson and Johnson
Chubb
Teva
Express Scripts
US Department of Justice
UBS
Accenture
Julphar

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,553,863

« Back to Dashboard

Which drugs does patent 7,553,863 protect, and when does it expire?

Patent 7,553,863 protects ANTIZOL and is included in one NDA.

This patent has nine patent family members in eight countries.
Summary for Patent: 7,553,863
Title:Ultrapure 4-methylpyrazole
Abstract:Disclosed is an ultrapure 4-methylpyrazole containing less than 0.1% pyrazole and containing less than 10 ppm each of hydrazine and nitrobenzaldehyde. The ultrapure 4-methylpyrazole is prepared by a novel process so that less than 0.01% of ethylvinyl ether is present.
Inventor(s): Reardan; Dayton T. (Shorewood, MN), Combe; Michel D. (Fox Point, WI)
Assignee: Paladin Labs (Barbados) Inc. (Barbados, BB)
Application Number:11/279,708
Patent Claim Types:
see list of patent claims
Formulation; Compound; Process; Composition;

Drugs Protected by US Patent 7,553,863

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Par Pharm Inc ANTIZOL fomepizole INJECTABLE;INJECTION 020696-001 Dec 4, 1997 AP RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,553,863

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2006240490 ➤ Sign Up
Canada 2605413 ➤ Sign Up
China 101163679 ➤ Sign Up
European Patent Office 1948613 ➤ Sign Up
Japan 2008538560 ➤ Sign Up
Japan 5378788 ➤ Sign Up
South Korea 20080000660 ➤ Sign Up
Mexico 2007013118 ➤ Sign Up
World Intellectual Property Organization (WIPO) 2006115626 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
US Department of Justice
Chinese Patent Office
Moodys
Colorcon
Fuji
Express Scripts
Citi
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot